Luminol sodium

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLuminol sodium
Drug Alias NameMP-1032
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-6 inhibitorsTumor necrosis factor α inhibitors
TargetsInterleukin-6Tumor necrosis factor α
Therapy Area/IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Immune System Diseases +[4] 
Global Approved IndicationsImmune System DiseasesPsoriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1997/01/01
Country/TerritoryBulgariaUnited StatesPoland +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSelvimMetrio
China Registration ClassN/A

Develop Information

Active CompaniesMetriopharm Ag
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Immune System DiseasesPsoriasis
Inactive IndicationsPlaque psoriasis

Other Information

ATC CodeD05A
Related LinksN/A